Dose-dependent GLI1 mRNA induction was also observed in human pancreatic cancer cells (AsPC1), in human breast carcinoma cells (MCF7), and in human embryonic kidney cells (Hek293A) (Figure 5D). Here, GLI1 is linked to pancreatic neoplasm.